ESMO 2012 Press Release: Myths and misunderstandings hamper efforts to prevent cancer
Studies presented at ESMO 2012 highlight challenges of cancer prevention
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Studies presented at ESMO 2012 highlight challenges of cancer prevention
Take a stroll down memory lane and check out the `hot´ topics from past ESMO congresses in Vienna
Long awaited results constitute a further milestone
It’s time cinema directors realised cancer isn’t always a death sentence, a new study shows
Phase III data reported at ESMO 2012
The first ever estimate of the economic burden of cancer in Europe shows that it exceeds 124 billion euros
811 people surveyed by Prof Tejpar and colleagues
New trial results on pazopanib and temsirolimus have important implications for patients
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.